Press Releases ICON Public Limited Company

Equities

Real-time Estimate Cboe BZX Other stock markets 10:40:56 2024-04-29 am EDT			5-day change	1st Jan Change
304.9 ^USD	-1.09%		+2.96%	+8.36%

Apr. 26	UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating	MT
Apr. 25	Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024

Icon PLC: Q1 Earnings Snapshot	Apr. 24	AQ
ICON Reports First Quarter 2024 Results	Apr. 24	BU
ICON Announces CFO Transition	Apr. 03	BU
ICON plc Schedules First Quarter 2024 Earnings Conference Call	Mar. 25	BU
ICON plc to Present at Upcoming Investor Conferences	Feb. 26	BU
ICON plc Reports Full Year 2023 Results	Feb. 22	AQ
Icon PLC: Q4 Earnings Snapshot	Feb. 21	AQ
ICON Reports Fourth Quarter and Full Year 2023 Results	Feb. 21	BU
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call	Jan. 31	AQ
ICON plc Schedules Q4 and Full Year 2023 Earnings Conference Call	Jan. 31	AQ
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call	Jan. 30	BU
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment	Jan. 24	BU
ICON Issues Financial Guidance for Full Year 2024	Jan. 09	BU
Biotech companies to increase R&D spend but highlight complexity of clinical trials, ICON	Jan. 09	AQ
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON	Jan. 08	BU
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 04	BU
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023	Dec. 18	BU
ICON secures upgraded credit rating from Moody's Investors Service	Dec. 08	AQ
ICON Secures Upgraded Credit Rating from Moody’s Investors Service	Dec. 07	BU
ICON plc to Present at Upcoming Investor Conferences	Nov. 08	BU

No results for this search